Player FM 앱으로 오프라인으로 전환하세요!
들어볼 가치가 있는 팟캐스트
스폰서 후원
1 How To Replace A $100,000+ Salary Within 6 MONTHS Through Buying A Small Business w/ Alex Kamenca & Carley Mitus 57:50
Circulation: Arrhythmia and Electrophysiology October 2020 Issue
Manage episode 282141819 series 1452724
Paul J. Wang:
Welcome to the monthly podcast, On the Beat for Circulation, Arrhythmia and Electrophysiology. I'm Dr. Paul Wang, editor-in-chief with some of the key highlights from this month's issue.
In our first paper, Bruce Wilkoff and associates evaluated antibacterial envelope cost effectiveness compared to standard of care infection prevention strategies in the US healthcare system. Decision tree model was used to compare costs and outcomes of the antimicrobial envelope used adjunctive to standard of care infection prevention versus standard of care alone over a lifelong time horizon. The analysis was performed from an integrated payer provider network perspective. Infection rates, antimicrobial envelope effectiveness, infection treatment costs and patterns, infection related mortality and utility estimates were obtained from the WRAP-IT study. Life expectancy and long-term costs associated with device replacement, follow-up, and healthcare utilization were sourced from the literature. Costs and quality life adjusted years were discounted at 3%. An upper willingness-to-pay threshold of $100,000 per quality adjusted life year was used to determine cost-effectiveness in alignment with the American College of Cardiology and American Heart Association practice guidelines and as supported by the World Health Organization and contemporary literature. The base case incremental cost-effectiveness ratio (ICER) of the antibacterial envelope compared with standard-of-care was $112,603 per quality-adjusted life year. The ICER remained lower than the threshold in 74% of iterations in the probabilistic sensitivity analysis and was most sensitive to the following model inputs: infection-related mortality, life expectancy, and infection cost. The authors concluded that the absorbable antibacterial envelope was associated with a cost-effectiveness ratio below contemporary benchmarks in the WRAP-IT patient population, suggesting that the envelope provides value for the US healthcare system by reducing the incidence of CIED infection.
In our next paper, Peter Loh and associates in this study aim to investigate the feasibility and safety of single pulse irreversible electroporation (IRE) pulmonary vein (PV) isolation in patients with atrial fibrillation (AF). Ten patients with symptomatic paroxysmal or persistent AF underwent single pulse IRE pulmonary vein isolation under general anesthesia. Three-dimensional reconstruction and electroanatomical voltage mapping of the left atrium and pulmonary veins were performed using a conventional circular mapping catheter. Pulmonary vein isolation was performed by delivering nonarcing, nonbarotraumatic 6 ms, 200 Joule direct current IRE applications via a custom nondeflectable 14-polar circular IRE ablation catheter with a variable hoop diameter (16–27 millimeters). A deflectable sheath was used to maneuver the ablation catheter. A minimum of 2 IRE applications with slightly different catheter positions were delivered per vein to achieve circular tissue contact, even if pulmonary vein potentials were abolished after the first application. Bidirectional pulmonary vein isolation was confirmed with the circular mapping catheter and a post ablation voltage map. After a 30-minute waiting period, adenosine testing was used to reveal dormant pulmonary vein conduction. All 40 pulmonary veins could be successfully isolated with a mean of 2.4 IRE applications per pulmonary vein. Mean delivery peak voltage and peak current were 2154 volts and 33.9 amperes. No pulmonary vein reconnections occurred during the waiting period and adenosine testing. No periprocedural complications were observed. The authors concluded that in 10 patients in this first in-human study, acute bidirectional electrical pulmonary vein isolation could be achieved safely using single pulse IRE ablation.
In our next paper, Christian Sohns and associates studied the relationship between left ventricular ejection fraction (LVEF) New York Heart Association (NYHA) class on presentation and the end points of mortality and heart failure (HF) admissions in the CASTLE-AF study population. Furthermore, predictors for LVEF improvement were examined. The CASTLE-AF patients with coexisting heart failure and AF (n=363) were randomized in a multicenter prospective controlled fashion to ablation (n=179) versus pharmacological therapy (n=184). Left ventricular function in NYHA class were assessed at baseline after randomization and at each follow-up visit. In the ablation arm, a significantly higher number of patients experienced an improvement in their LVEF to greater than 35% at the end of the study (odds ratio, 2.17; P
42 에피소드
Manage episode 282141819 series 1452724
Paul J. Wang:
Welcome to the monthly podcast, On the Beat for Circulation, Arrhythmia and Electrophysiology. I'm Dr. Paul Wang, editor-in-chief with some of the key highlights from this month's issue.
In our first paper, Bruce Wilkoff and associates evaluated antibacterial envelope cost effectiveness compared to standard of care infection prevention strategies in the US healthcare system. Decision tree model was used to compare costs and outcomes of the antimicrobial envelope used adjunctive to standard of care infection prevention versus standard of care alone over a lifelong time horizon. The analysis was performed from an integrated payer provider network perspective. Infection rates, antimicrobial envelope effectiveness, infection treatment costs and patterns, infection related mortality and utility estimates were obtained from the WRAP-IT study. Life expectancy and long-term costs associated with device replacement, follow-up, and healthcare utilization were sourced from the literature. Costs and quality life adjusted years were discounted at 3%. An upper willingness-to-pay threshold of $100,000 per quality adjusted life year was used to determine cost-effectiveness in alignment with the American College of Cardiology and American Heart Association practice guidelines and as supported by the World Health Organization and contemporary literature. The base case incremental cost-effectiveness ratio (ICER) of the antibacterial envelope compared with standard-of-care was $112,603 per quality-adjusted life year. The ICER remained lower than the threshold in 74% of iterations in the probabilistic sensitivity analysis and was most sensitive to the following model inputs: infection-related mortality, life expectancy, and infection cost. The authors concluded that the absorbable antibacterial envelope was associated with a cost-effectiveness ratio below contemporary benchmarks in the WRAP-IT patient population, suggesting that the envelope provides value for the US healthcare system by reducing the incidence of CIED infection.
In our next paper, Peter Loh and associates in this study aim to investigate the feasibility and safety of single pulse irreversible electroporation (IRE) pulmonary vein (PV) isolation in patients with atrial fibrillation (AF). Ten patients with symptomatic paroxysmal or persistent AF underwent single pulse IRE pulmonary vein isolation under general anesthesia. Three-dimensional reconstruction and electroanatomical voltage mapping of the left atrium and pulmonary veins were performed using a conventional circular mapping catheter. Pulmonary vein isolation was performed by delivering nonarcing, nonbarotraumatic 6 ms, 200 Joule direct current IRE applications via a custom nondeflectable 14-polar circular IRE ablation catheter with a variable hoop diameter (16–27 millimeters). A deflectable sheath was used to maneuver the ablation catheter. A minimum of 2 IRE applications with slightly different catheter positions were delivered per vein to achieve circular tissue contact, even if pulmonary vein potentials were abolished after the first application. Bidirectional pulmonary vein isolation was confirmed with the circular mapping catheter and a post ablation voltage map. After a 30-minute waiting period, adenosine testing was used to reveal dormant pulmonary vein conduction. All 40 pulmonary veins could be successfully isolated with a mean of 2.4 IRE applications per pulmonary vein. Mean delivery peak voltage and peak current were 2154 volts and 33.9 amperes. No pulmonary vein reconnections occurred during the waiting period and adenosine testing. No periprocedural complications were observed. The authors concluded that in 10 patients in this first in-human study, acute bidirectional electrical pulmonary vein isolation could be achieved safely using single pulse IRE ablation.
In our next paper, Christian Sohns and associates studied the relationship between left ventricular ejection fraction (LVEF) New York Heart Association (NYHA) class on presentation and the end points of mortality and heart failure (HF) admissions in the CASTLE-AF study population. Furthermore, predictors for LVEF improvement were examined. The CASTLE-AF patients with coexisting heart failure and AF (n=363) were randomized in a multicenter prospective controlled fashion to ablation (n=179) versus pharmacological therapy (n=184). Left ventricular function in NYHA class were assessed at baseline after randomization and at each follow-up visit. In the ablation arm, a significantly higher number of patients experienced an improvement in their LVEF to greater than 35% at the end of the study (odds ratio, 2.17; P
42 에피소드
모든 에피소드
×1 Circulation: Arrhythmia and Electrophysiology November 2020 Issue 46:14
1 Circulation: Arrhythmia and Electrophysiology October 2020 Issue 37:09
1 Circulation: Arrhythmia and Electrophysiology September 2020 Issue 34:30
1 Circulation: Arrhythmia and Electrophysiology July 2020 Issue 19:47
1 Circulation: Arrhythmia and Electrophysiology August 2020 Issue 36:14
1 Circulation: Arrhythmia and Electrophysiology June 2020 Issue 19:19
1 Circulation: Arrhythmia and Electrophysiology May 2020 Issue 17:49
1 Circulation: Arrhythmia and Electrophysiology April 2020 Issue 12:56
1 Circulation: Arrhythmia and Electrophysiology March 2020 Issue 16:05
1 Circulation: Arrhythmia and Electrophysiology February 2020 Issue 12:57
1 Circulation: Arrhythmia and Electrophysiology January 2020 Issue 16:47
1 Circulation: Arrhythmia and Electrophysiology December 2019 Issue 16:53
1 Circulation: Arrhythmia and Electrophysiology November 2019 Issue 15:24
1 Circulation: Arrhythmia and Electrophysiology October 2019 Issue 16:00
1 Circulation: Arrhythmia and Electrophysiology September 2019 Issue 14:31
1 Circulation: Arrhythmia and Electrophysiology August 2019 Issue 13:34
1 Circulation: Arrhythmia and Electrophysiology July 2018 Issue 15:30
1 Circulation: Arrhythmia and Electrophysiology June 2019 Issue 17:20
1 Circulation: Arrhythmia and Electrophysiology May 2019 Issue 11:29
1 Circulation: Arrhythmia and Electrophysiology April 2019 Issue 11:37
1 Circulation: Arrhythmia and Electrophysiology March 2019 Issue 15:22
1 Circulation: Arrhythmia and Electrophysiology February 2019 Issue 9:29
1 Circulation: Arrhythmia and Electrophysiology january 2019 Issue 11:26
1 Circulation: Arrhythmia and Electrophysiology December 2018 Issue 14:14
1 Circulation: Arrhythmia and Electrophysiology October 2018 Issue 14:09
1 Circulation: Arrhythmia and Electrophysiology September 2018 Issue 11:31
1 Circulation: Arrhythmia and Electrophysiology August 2018 Issue 10:06
1 Circulation: Arrhythmia and Electrophysiology on the Beat July 2018 16:02
1 Circulation: Arrhythmia and Electrophysiology On the Beat June 2018 14:40
1 Circulation: Arrhythmia and Electrophysiology On the Beat May 2018 15:15
1 Circulation: Arrhythmia and Electrophysiology On the Beat April 2018 1:07:38
1 Circulation: Arrhythmia and Electrophysiology On the Beat March 2018 1:20:30
1 Circulation: Arrhythmia and Electrophysiology On the Beat February 2018 54:25
1 Circulation: Arrhythmia and Electrophysiology On the Beat January 2018 47:18
1 Circulation: Arrhythmia and Electrophysiology On the Beat December 2017 1:04:28
1 Circulation: Arrhythmia and Electrophysiology On the Beat November 2017 55:24
1 Circulation: Arrhythmia and Electrophysiology On the Beat October 2017 1:00:17
1 Circulation: Arrhythmia and Electrophysiology On the Beat September 2017 1:04:27
1 Circulation: Arrhythmia and Electrophysiology On the Beat August 2017 50:36
1 Circulation: Arrhythmia and Electrophysiology On the Beat July 2017 39:06
플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.